Myopic shift and lens turbidity following hyperbaric oxygen therapy – a prospective, longitudinal, observational cohort study
Purpose To examine visual acuity, refraction and ocular status before, during and after hyperbaric oxygen therapy (HBOT). Methods Twenty‐nine patients underwent 40 standard protocol HBOT treatments. In all subjects, refraction and best corrected visual acuity were measured at baseline and after ten,...
Saved in:
| Published in | Acta ophthalmologica (Oxford, England) Vol. 97; no. 6; pp. 596 - 602 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Wiley Subscription Services, Inc
01.09.2019
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Purpose
To examine visual acuity, refraction and ocular status before, during and after hyperbaric oxygen therapy (HBOT).
Methods
Twenty‐nine patients underwent 40 standard protocol HBOT treatments. In all subjects, refraction and best corrected visual acuity were measured at baseline and after ten, 20, 30 and 40 treatments, and at a 12‐week follow‐up. A subgroup (n = 19) were given additional examinations at baseline, after 40 treatments and at follow‐up including measuring central corneal thickness (CCT), corneal curvature, anterior chamber depth, lens thickness, axial length, fundus morphology, blood pressure and intraocular pressure (IOP). Lens colour and opalescence were graded using the Lens Opacities Classification System III (LOCS III).
Results
Myopic shifts [≥0.5 dioptre (D) spherical equivalent (SE)] occurred in 45 (77.6%) eyes. Median refractive changes of −0.75 D SE (right eye; p < 0.001) and −0.66 D SE (left eye; p < 0.001) were observed between pretreatment and treatment end (Wilcoxon signed rank test). Refraction returned to baseline at follow‐up, except for a small persisting change towards myopia, median –0.25 D SE (left eye; p = 0.01). Using the LOCS III, median increases in lens nuclear colour, of 0.6 (right eye; p < 0.001) and 0.7 (left eye; p < 0.001), and opalescence of 0.7 (both eyes; p = 0.01) were found at the last examination. Small reductions were noted in CCT of −6.00 μm (right eye; p = 0.03) and −4.00 μm (left eye; p = 0.03), and IOP of −1.50 mmHg (left eye; p = 0.01).
Conclusions
The transient myopic shift may have been due to lenticular refractive index changes. Reduced lens transparency is a potential consequence of HBOT. |
|---|---|
| AbstractList | PURPOSE: To examine visual acuity, refraction and ocular status before, during and after hyperbaric oxygen therapy (HBOT).
METHODS: Twenty-nine patients underwent 40 standard protocol HBOT treatments. In all subjects, refraction and best corrected visual acuity were measured at baseline and after ten, 20, 30 and 40 treatments, and at a 12-week follow-up. A subgroup (n = 19) were given additional examinations at baseline, after 40 treatments and at follow-up including measuring central corneal thickness (CCT), corneal curvature, anterior chamber depth, lens thickness, axial length, fundus morphology, blood pressure and intraocular pressure (IOP). Lens colour and opalescence were graded using the Lens Opacities Classification System III (LOCS III).
RESULTS: Myopic shifts [≥0.5 dioptre (D) spherical equivalent (SE)] occurred in 45 (77.6%) eyes. Median refractive changes of -0.75 D SE (right eye; p < 0.001) and -0.66 D SE (left eye; p < 0.001) were observed between pretreatment and treatment end (Wilcoxon signed rank test). Refraction returned to baseline at follow-up, except for a small persisting change towards myopia, median -0.25 D SE (left eye; p = 0.01). Using the LOCS III, median increases in lens nuclear colour, of 0.6 (right eye; p < 0.001) and 0.7 (left eye; p < 0.001), and opalescence of 0.7 (both eyes; p = 0.01) were found at the last examination. Small reductions were noted in CCT of -6.00 μm (right eye; p = 0.03) and -4.00 μm (left eye; p = 0.03), and IOP of -1.50 mmHg (left eye; p = 0.01).
CONCLUSIONS: The transient myopic shift may have been due to lenticular refractive index changes. Reduced lens transparency is a potential consequence of HBOT. PurposeTo examine visual acuity, refraction and ocular status before, during and after hyperbaric oxygen therapy (HBOT).MethodsTwenty‐nine patients underwent 40 standard protocol HBOT treatments. In all subjects, refraction and best corrected visual acuity were measured at baseline and after ten, 20, 30 and 40 treatments, and at a 12‐week follow‐up. A subgroup (n = 19) were given additional examinations at baseline, after 40 treatments and at follow‐up including measuring central corneal thickness (CCT), corneal curvature, anterior chamber depth, lens thickness, axial length, fundus morphology, blood pressure and intraocular pressure (IOP). Lens colour and opalescence were graded using the Lens Opacities Classification System III (LOCS III).ResultsMyopic shifts [≥0.5 dioptre (D) spherical equivalent (SE)] occurred in 45 (77.6%) eyes. Median refractive changes of −0.75 D SE (right eye; p < 0.001) and −0.66 D SE (left eye; p < 0.001) were observed between pretreatment and treatment end (Wilcoxon signed rank test). Refraction returned to baseline at follow‐up, except for a small persisting change towards myopia, median –0.25 D SE (left eye; p = 0.01). Using the LOCS III, median increases in lens nuclear colour, of 0.6 (right eye; p < 0.001) and 0.7 (left eye; p < 0.001), and opalescence of 0.7 (both eyes; p = 0.01) were found at the last examination. Small reductions were noted in CCT of −6.00 μm (right eye; p = 0.03) and −4.00 μm (left eye; p = 0.03), and IOP of −1.50 mmHg (left eye; p = 0.01).ConclusionsThe transient myopic shift may have been due to lenticular refractive index changes. Reduced lens transparency is a potential consequence of HBOT. Purpose To examine visual acuity, refraction and ocular status before, during and after hyperbaric oxygen therapy (HBOT). Methods Twenty‐nine patients underwent 40 standard protocol HBOT treatments. In all subjects, refraction and best corrected visual acuity were measured at baseline and after ten, 20, 30 and 40 treatments, and at a 12‐week follow‐up. A subgroup (n = 19) were given additional examinations at baseline, after 40 treatments and at follow‐up including measuring central corneal thickness (CCT), corneal curvature, anterior chamber depth, lens thickness, axial length, fundus morphology, blood pressure and intraocular pressure (IOP). Lens colour and opalescence were graded using the Lens Opacities Classification System III (LOCS III). Results Myopic shifts [≥0.5 dioptre (D) spherical equivalent (SE)] occurred in 45 (77.6%) eyes. Median refractive changes of −0.75 D SE (right eye; p < 0.001) and −0.66 D SE (left eye; p < 0.001) were observed between pretreatment and treatment end (Wilcoxon signed rank test). Refraction returned to baseline at follow‐up, except for a small persisting change towards myopia, median –0.25 D SE (left eye; p = 0.01). Using the LOCS III, median increases in lens nuclear colour, of 0.6 (right eye; p < 0.001) and 0.7 (left eye; p < 0.001), and opalescence of 0.7 (both eyes; p = 0.01) were found at the last examination. Small reductions were noted in CCT of −6.00 μm (right eye; p = 0.03) and −4.00 μm (left eye; p = 0.03), and IOP of −1.50 mmHg (left eye; p = 0.01). Conclusions The transient myopic shift may have been due to lenticular refractive index changes. Reduced lens transparency is a potential consequence of HBOT. To examine visual acuity, refraction and ocular status before, during and after hyperbaric oxygen therapy (HBOT). Twenty-nine patients underwent 40 standard protocol HBOT treatments. In all subjects, refraction and best corrected visual acuity were measured at baseline and after ten, 20, 30 and 40 treatments, and at a 12-week follow-up. A subgroup (n = 19) were given additional examinations at baseline, after 40 treatments and at follow-up including measuring central corneal thickness (CCT), corneal curvature, anterior chamber depth, lens thickness, axial length, fundus morphology, blood pressure and intraocular pressure (IOP). Lens colour and opalescence were graded using the Lens Opacities Classification System III (LOCS III). Myopic shifts [≥0.5 dioptre (D) spherical equivalent (SE)] occurred in 45 (77.6%) eyes. Median refractive changes of -0.75 D SE (right eye; p < 0.001) and -0.66 D SE (left eye; p < 0.001) were observed between pretreatment and treatment end (Wilcoxon signed rank test). Refraction returned to baseline at follow-up, except for a small persisting change towards myopia, median -0.25 D SE (left eye; p = 0.01). Using the LOCS III, median increases in lens nuclear colour, of 0.6 (right eye; p < 0.001) and 0.7 (left eye; p < 0.001), and opalescence of 0.7 (both eyes; p = 0.01) were found at the last examination. Small reductions were noted in CCT of -6.00 μm (right eye; p = 0.03) and -4.00 μm (left eye; p = 0.03), and IOP of -1.50 mmHg (left eye; p = 0.01). The transient myopic shift may have been due to lenticular refractive index changes. Reduced lens transparency is a potential consequence of HBOT. To examine visual acuity, refraction and ocular status before, during and after hyperbaric oxygen therapy (HBOT).Twenty-nine patients underwent 40 standard protocol HBOT treatments. In all subjects, refraction and best corrected visual acuity were measured at baseline and after ten, 20, 30 and 40 treatments, and at a 12-week follow-up. A subgroup (n=19) were given additional examinations at baseline, after 40 treatments and at follow-up including measuring central corneal thickness (CCT), corneal curvature, anterior chamber depth, lens thickness, axial length, fundus morphology, blood pressure and intraocular pressure (IOP). Lens colour and opalescence were graded using the Lens Opacities Classification System III (LOCS III).Myopic shifts [≥0.5 dioptre (D) spherical equivalent (SE)] occurred in 45 (77.6%) eyes. Median refractive changes of -0.75 D SE (right eye; p<0.001) and -0.66 D SE (left eye; p<0.001) were observed between pretreatment and treatment end (Wilcoxon signed rank test). Refraction returned to baseline at follow-up, except for a small persisting change towards myopia, median -0.25 D SE (left eye; p=0.01). Using the LOCS III, median increases in lens nuclear colour, of 0.6 (right eye; p<0.001) and 0.7 (left eye; p<0.001), and opalescence of 0.7 (both eyes; p=0.01) were found at the last examination. Small reductions were noted in CCT of -6.00μm (right eye; p=0.03) and -4.00μm (left eye; p=0.03), and IOP of -1.50mmHg (left eye; p=0.01).The transient myopic shift may have been due to lenticular refractive index changes. Reduced lens transparency is a potential consequence of HBOT. To examine visual acuity, refraction and ocular status before, during and after hyperbaric oxygen therapy (HBOT).PURPOSETo examine visual acuity, refraction and ocular status before, during and after hyperbaric oxygen therapy (HBOT).Twenty-nine patients underwent 40 standard protocol HBOT treatments. In all subjects, refraction and best corrected visual acuity were measured at baseline and after ten, 20, 30 and 40 treatments, and at a 12-week follow-up. A subgroup (n = 19) were given additional examinations at baseline, after 40 treatments and at follow-up including measuring central corneal thickness (CCT), corneal curvature, anterior chamber depth, lens thickness, axial length, fundus morphology, blood pressure and intraocular pressure (IOP). Lens colour and opalescence were graded using the Lens Opacities Classification System III (LOCS III).METHODSTwenty-nine patients underwent 40 standard protocol HBOT treatments. In all subjects, refraction and best corrected visual acuity were measured at baseline and after ten, 20, 30 and 40 treatments, and at a 12-week follow-up. A subgroup (n = 19) were given additional examinations at baseline, after 40 treatments and at follow-up including measuring central corneal thickness (CCT), corneal curvature, anterior chamber depth, lens thickness, axial length, fundus morphology, blood pressure and intraocular pressure (IOP). Lens colour and opalescence were graded using the Lens Opacities Classification System III (LOCS III).Myopic shifts [≥0.5 dioptre (D) spherical equivalent (SE)] occurred in 45 (77.6%) eyes. Median refractive changes of -0.75 D SE (right eye; p < 0.001) and -0.66 D SE (left eye; p < 0.001) were observed between pretreatment and treatment end (Wilcoxon signed rank test). Refraction returned to baseline at follow-up, except for a small persisting change towards myopia, median -0.25 D SE (left eye; p = 0.01). Using the LOCS III, median increases in lens nuclear colour, of 0.6 (right eye; p < 0.001) and 0.7 (left eye; p < 0.001), and opalescence of 0.7 (both eyes; p = 0.01) were found at the last examination. Small reductions were noted in CCT of -6.00 μm (right eye; p = 0.03) and -4.00 μm (left eye; p = 0.03), and IOP of -1.50 mmHg (left eye; p = 0.01).RESULTSMyopic shifts [≥0.5 dioptre (D) spherical equivalent (SE)] occurred in 45 (77.6%) eyes. Median refractive changes of -0.75 D SE (right eye; p < 0.001) and -0.66 D SE (left eye; p < 0.001) were observed between pretreatment and treatment end (Wilcoxon signed rank test). Refraction returned to baseline at follow-up, except for a small persisting change towards myopia, median -0.25 D SE (left eye; p = 0.01). Using the LOCS III, median increases in lens nuclear colour, of 0.6 (right eye; p < 0.001) and 0.7 (left eye; p < 0.001), and opalescence of 0.7 (both eyes; p = 0.01) were found at the last examination. Small reductions were noted in CCT of -6.00 μm (right eye; p = 0.03) and -4.00 μm (left eye; p = 0.03), and IOP of -1.50 mmHg (left eye; p = 0.01).The transient myopic shift may have been due to lenticular refractive index changes. Reduced lens transparency is a potential consequence of HBOT.CONCLUSIONSThe transient myopic shift may have been due to lenticular refractive index changes. Reduced lens transparency is a potential consequence of HBOT. |
| Author | Zetterberg, Madeleine Andersson Grönlund, Marita Wannholt, Roger Riedl, Philip Arnell, Per Škiljić, Dragana |
| Author_xml | – sequence: 1 givenname: Philip orcidid: 0000-0002-3856-2282 surname: Riedl fullname: Riedl, Philip organization: Sahlgrenska University Hospital – sequence: 2 givenname: Dragana orcidid: 0000-0002-9220-7767 surname: Škiljić fullname: Škiljić, Dragana organization: Sahlgrenska University Hospital – sequence: 3 givenname: Per surname: Arnell fullname: Arnell, Per organization: Sahlgrenska University Hospital – sequence: 4 givenname: Roger surname: Wannholt fullname: Wannholt, Roger organization: Sahlgrenska University Hospital – sequence: 5 givenname: Madeleine surname: Zetterberg fullname: Zetterberg, Madeleine organization: Sahlgrenska University Hospital – sequence: 6 givenname: Marita surname: Andersson Grönlund fullname: Andersson Grönlund, Marita email: marita.gronlund@neuro.gu.se organization: Sahlgrenska University Hospital |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30690920$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-103792$$DView record from Swedish Publication Index https://gup.ub.gu.se/publication/278674$$DView record from Swedish Publication Index |
| BookMark | eNp90stqHSEYAGApKc2lXfQFitBNAzmJOo7OLA_pFVKyaCjdiTrOHINnnHrJ6azSd-gb9klqc9KzCDSCePsU-f__EOyNfjQAvMToFJd2Jn08xRRh9AQcYF7Xi4qzZm83r7_tg8MYrxFimDH6DOxXiLWoJegA3H6e_WQ1jCvbJyjHDjozRphyULazaYa9d85v7DjA1TyZoGQo2v-YBzPCtDJBTjP8_fMXlHAKPk5GJ3tjTqDz42BT7uwo3Qn0KppwI5P1ZQm1X_mQYCzH83PwtJcumhf34xG4ev_u6vzj4uLyw6fz5cVCU0bRQldSG4lqihTRqOOo5RzjTre9qXouW0VxZVjTK8aapm5JxyRriKoR67hUfXUEFttn48ZMWYkp2LUMs_DSiiFPomwNWUQjCG8Yp4_6t_brUvgwlJ4FRhVvSfFvtr4E4Xs2MYm1jdo4J0fjcxQE85YSRBtc6OsH9NrnUOJSFGFtyRyhdVGv7lVWa9PtPvAvcwUcb4EuYY_B9DuCkfhbFaJUhbirimLPHlht0102UpDWPXZjY52Z__-0WF5-2d74A2MXy8o |
| CitedBy_id | crossref_primary_10_1002_prot_26391 crossref_primary_10_3390_vision6010017 crossref_primary_10_1080_17469899_2020_1739523 crossref_primary_10_3390_jcm13010029 crossref_primary_10_1016_j_exer_2021_108790 crossref_primary_10_1016_j_oftale_2020_07_019 crossref_primary_10_1016_j_oftal_2020_07_024 crossref_primary_10_3390_ctn7040041 crossref_primary_10_3390_ijms26031067 crossref_primary_10_28920_dhm54_4_328_337 crossref_primary_10_1177_25158414241280187 |
| Cites_doi | 10.1136/bjo.71.6.405 10.1016/S0161-6420(02)01094-1 10.1111/j.1395-3907.2004.00290.x 10.1001/archopht.1993.01090060119035 10.1016/S0002-9394(99)00218-4 10.1034/j.1600-0420.2002.800213.x 10.1097/OPX.0b013e318213f001 10.1016/0014-4835(72)90028-0 10.1167/iovs.05-0843 10.1097/00006324-199607000-00006 10.1159/000327703 10.1089/jop.2000.16.121 10.1097/OPX.0000000000000705 10.1167/iovs.03-0122 10.1136/bjo.68.2.113 |
| ContentType | Journal Article |
| Copyright | 2019 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd 2019 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd. Copyright © 2019 Acta Ophthalmologica Scandinavica Foundation |
| Copyright_xml | – notice: 2019 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd – notice: 2019 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd. – notice: Copyright © 2019 Acta Ophthalmologica Scandinavica Foundation |
| DBID | AAYXX CITATION NPM 7TK 7X8 ADTPV AOWAS D91 F1U |
| DOI | 10.1111/aos.14010 |
| DatabaseName | CrossRef PubMed Neurosciences Abstracts MEDLINE - Academic SwePub SwePub Articles SWEPUB Örebro universitet SWEPUB Göteborgs universitet |
| DatabaseTitle | CrossRef PubMed Neurosciences Abstracts MEDLINE - Academic |
| DatabaseTitleList | Neurosciences Abstracts PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1755-3768 |
| EndPage | 602 |
| ExternalDocumentID | oai_gup_ub_gu_se_278674 oai_DiVA_org_oru_103792 30690920 10_1111_aos_14010 AOS14010 |
| Genre | article Journal Article |
| GrantInformation_xml | – fundername: Agreement concerning the research and education of doctors funderid: ALFGBG‐719331; ALFGBG‐725041 – fundername: Agreement concerning the research and education of doctors grantid: ALFGBG-725041 – fundername: Agreement concerning the research and education of doctors grantid: ALFGBG-719331 |
| GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 1OC 23M 24P 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACGFS ACGOF ACMXC ACNCT ACPOU ACPRK ACSCC ACUHS ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FIJ FUBAC G-S GODZA H.X HF~ HGLYW HZI HZ~ IPNFZ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2W P2X P2Z P4B P4D P6G PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SUPJJ SV3 TEORI TR2 TUS UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WVDHM WXI WXSBR X7M XG1 ~IA ~WT AAYXX AEYWJ AGHNM AGYGG CITATION NPM 1OB 7TK AAMMB AEFGJ AGXDD AIDQK AIDYY 7X8 ADTPV AOWAS D91 F1U |
| ID | FETCH-LOGICAL-c4640-c3acea0540b2c0d7097711dc9fe3f7a9b413e68fb6688592d6a682b506d7abf3 |
| IEDL.DBID | DR2 |
| ISSN | 1755-375X 1755-3768 |
| IngestDate | Thu Aug 21 06:18:49 EDT 2025 Thu Aug 21 07:09:58 EDT 2025 Tue Aug 05 10:40:58 EDT 2025 Wed Aug 13 03:45:57 EDT 2025 Wed Feb 19 02:36:22 EST 2025 Thu Apr 24 22:57:09 EDT 2025 Tue Jul 01 01:55:21 EDT 2025 Wed Jan 22 16:40:45 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | myopic shift myopia hyperbaric oxygen therapy cataract oxidative stress |
| Language | English |
| License | 2019 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4640-c3acea0540b2c0d7097711dc9fe3f7a9b413e68fb6688592d6a682b506d7abf3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
| ORCID | 0000-0002-9220-7767 0000-0002-3856-2282 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/aos.14010 |
| PMID | 30690920 |
| PQID | 2269768245 |
| PQPubID | 1036384 |
| PageCount | 7 |
| ParticipantIDs | swepub_primary_oai_gup_ub_gu_se_278674 swepub_primary_oai_DiVA_org_oru_103792 proquest_miscellaneous_2179420481 proquest_journals_2269768245 pubmed_primary_30690920 crossref_primary_10_1111_aos_14010 crossref_citationtrail_10_1111_aos_14010 wiley_primary_10_1111_aos_14010_AOS14010 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | September 2019 |
| PublicationDateYYYYMMDD | 2019-09-01 |
| PublicationDate_xml | – month: 09 year: 2019 text: September 2019 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Malden |
| PublicationTitle | Acta ophthalmologica (Oxford, England) |
| PublicationTitleAlternate | Acta Ophthalmol |
| PublicationYear | 2019 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2004; 82 1987; 71 2015; 92 2011 1978; 76 1978; 98 1984; 106 1984; 68 2009 1996; 73 1970 1999; 40 2002; 80 2014; 41 1999; 128 2005; 46 2001; 42 2000; 16 1988; 29 2002; 43 2011; 88 2014 1980 2002; 109 2012; 47 1972; 13 1996; 67 2003; 44 1993; 111 e_1_2_5_27_1 e_1_2_5_25_1 e_1_2_5_26_1 Weaver L (e_1_2_5_28_1) 2014 e_1_2_5_24_1 e_1_2_5_21_1 e_1_2_5_22_1 Wong TY (e_1_2_5_29_1) 2001; 42 Lerman SL (e_1_2_5_16_1) 1980 Anderson B (e_1_2_5_2_1) 1978; 76 e_1_2_5_17_1 Evanger K (e_1_2_5_9_1) 2014; 41 e_1_2_5_8_1 e_1_2_5_11_1 e_1_2_5_7_1 e_1_2_5_10_1 e_1_2_5_13_1 e_1_2_5_5_1 Goss DA (e_1_2_5_14_1) 1996; 67 Jain K (e_1_2_5_15_1) 2009 e_1_2_5_4_1 e_1_2_5_3_1 Lyne AJ (e_1_2_5_20_1) 1978; 98 Levin LA (e_1_2_5_18_1) 2011 Lim R (e_1_2_5_19_1) 1999; 40 Duke‐Elder S (e_1_2_5_6_1) 1970 Giblin FJ (e_1_2_5_12_1) 1988; 29 Reddy VN (e_1_2_5_23_1) 1984; 106 Younan C (e_1_2_5_30_1) 2002; 43 |
| References_xml | – year: 2011 – volume: 92 start-page: 1076 year: 2015 end-page: 1084 article-title: Myopic shift during hyperbaric oxygenation attributed to lens index changes publication-title: Optom Vis Sci – year: 2009 – volume: 82 start-page: 449 year: 2004 end-page: 453 article-title: Ocular refractive changes in patients receiving hyperbaric oxygen administered by oronasal mask or hood publication-title: Acta Ophthalmol Scand – volume: 128 start-page: 446 year: 1999 end-page: 465 article-title: The epidemiology of cataract in Australia publication-title: Am J Ophthalmol – volume: 111 start-page: 831 year: 1993 end-page: 836 article-title: The lens opacities classification system III. The Longitudinal Study of Cataract Study Group publication-title: Arch Ophthalmol – volume: 46 start-page: 4641 year: 2005 end-page: 4651 article-title: Aggregation of lens crystallins in an in vivo hyperbaric oxygen guinea pig model of nuclear cataract: dynamic light‐scattering and HPLC analysis publication-title: Invest Ophthalmol Vis Sci – volume: 29 start-page: 1312 year: 1988 end-page: 1319 article-title: Exposure of rabbit lens to hyperbaric oxygen in vitro: regional effects on GSH level publication-title: Invest Ophthalmol Vis Sci – volume: 98 start-page: 66 year: 1978 end-page: 68 article-title: Ocular effects of hyperbaric oxygen publication-title: Trans Ophthalmol Soc UK – volume: 109 start-page: 1303 year: 2002 end-page: 1308 article-title: Risk factors for incident nuclear opacities publication-title: Ophthalmology – volume: 41 start-page: 589 year: 2014 end-page: 596 article-title: Posterior segment changes of the eye during hyperbaric oxygen therapy publication-title: Undersea Hyperb Med – volume: 80 start-page: 188 year: 2002 end-page: 190 article-title: Refractive change during hyperbaric oxygen therapy. A clinical trial including ultrasound oculometry publication-title: Acta Ophthalmol Scand – year: 2014 – volume: 106 start-page: 65 year: 1984 end-page: 87 article-title: Metabolism and function of glutathione in the lens publication-title: Ciba Found Symp – volume: 68 start-page: 113 year: 1984 end-page: 117 article-title: Nuclear cataract and myopia during hyperbaric oxygen therapy publication-title: Br J Ophthalmol – volume: 13 start-page: 155 year: 1972 end-page: 160 article-title: The human lens. 3. Some observations on the post‐mortem lens publication-title: Exp Eye Res – year: 1980 – volume: 44 start-page: 3476 year: 2003 end-page: 3484 article-title: Lenticular oxygen toxicity publication-title: Invest Ophthalmol Vis Sci – volume: 43 start-page: 3625 year: 2002 end-page: 3632 article-title: Myopia and incident cataract and cataract surgery: the blue mountains eye study publication-title: Invest Ophthalmol Vis Sci – volume: 47 start-page: 19 year: 2012 end-page: 22 article-title: Influence of hyperbaric oxygen therapy on central corneal thickness publication-title: Ophthalmic Res – volume: 42 start-page: 1449 year: 2001 end-page: 1454 article-title: Refractive errors and incident cataracts: the Beaver Dam Eye Study publication-title: Invest Ophthalmol Vis Sci – volume: 71 start-page: 405 year: 1987 end-page: 414 article-title: Cataract: the relation between myopia and cataract morphology publication-title: Br J Ophthalmol – year: 1970 – volume: 67 start-page: 619 year: 1996 end-page: 630 article-title: Reliability of refraction–a literature review publication-title: J Am Optom Assoc – volume: 88 start-page: 691 year: 2011 end-page: 696 article-title: Phakic and pseudophakic eyes in patients during hyperbaric oxygen therapy publication-title: Optom Vis Sci – volume: 73 start-page: 487 year: 1996 end-page: 494 article-title: Myopia associated with hyperbaric oxygen therapy publication-title: Optom Vis Sci – volume: 16 start-page: 121 year: 2000 end-page: 135 article-title: Glutathione: a vital lens antioxidant publication-title: J Ocul Pharmacol Ther – volume: 40 start-page: 3021 year: 1999 end-page: 3026 article-title: Refractive associations with cataract: the Blue Mountains Eye Study publication-title: Invest Ophthalmol Vis Sci – volume: 76 start-page: 116 year: 1978 end-page: 124 article-title: Hyperoxic myopia publication-title: Trans Am Ophthalmol Soc – ident: e_1_2_5_4_1 doi: 10.1136/bjo.71.6.405 – ident: e_1_2_5_17_1 doi: 10.1016/S0161-6420(02)01094-1 – volume: 76 start-page: 116 year: 1978 ident: e_1_2_5_2_1 article-title: Hyperoxic myopia publication-title: Trans Am Ophthalmol Soc – volume: 40 start-page: 3021 year: 1999 ident: e_1_2_5_19_1 article-title: Refractive associations with cataract: the Blue Mountains Eye Study publication-title: Invest Ophthalmol Vis Sci – volume: 42 start-page: 1449 year: 2001 ident: e_1_2_5_29_1 article-title: Refractive errors and incident cataracts: the Beaver Dam Eye Study publication-title: Invest Ophthalmol Vis Sci – ident: e_1_2_5_7_1 doi: 10.1111/j.1395-3907.2004.00290.x – volume: 106 start-page: 65 year: 1984 ident: e_1_2_5_23_1 article-title: Metabolism and function of glutathione in the lens publication-title: Ciba Found Symp – volume-title: Adler's Physiology of the Eye year: 2011 ident: e_1_2_5_18_1 – volume-title: System of ophthalmology year: 1970 ident: e_1_2_5_6_1 – volume: 41 start-page: 589 year: 2014 ident: e_1_2_5_9_1 article-title: Posterior segment changes of the eye during hyperbaric oxygen therapy publication-title: Undersea Hyperb Med – ident: e_1_2_5_5_1 doi: 10.1001/archopht.1993.01090060119035 – ident: e_1_2_5_21_1 doi: 10.1016/S0002-9394(99)00218-4 – volume: 43 start-page: 3625 year: 2002 ident: e_1_2_5_30_1 article-title: Myopia and incident cataract and cataract surgery: the blue mountains eye study publication-title: Invest Ophthalmol Vis Sci – volume-title: Textbook of hyperbaric medicine year: 2009 ident: e_1_2_5_15_1 – volume-title: Hyperbaric oxygen therapy indications year: 2014 ident: e_1_2_5_28_1 – volume: 29 start-page: 1312 year: 1988 ident: e_1_2_5_12_1 article-title: Exposure of rabbit lens to hyperbaric oxygen in vitro: regional effects on GSH level publication-title: Invest Ophthalmol Vis Sci – ident: e_1_2_5_11_1 doi: 10.1034/j.1600-0420.2002.800213.x – ident: e_1_2_5_8_1 doi: 10.1097/OPX.0b013e318213f001 – volume-title: Radiant energy and the eye year: 1980 ident: e_1_2_5_16_1 – volume: 98 start-page: 66 year: 1978 ident: e_1_2_5_20_1 article-title: Ocular effects of hyperbaric oxygen publication-title: Trans Ophthalmol Soc UK – ident: e_1_2_5_27_1 doi: 10.1016/0014-4835(72)90028-0 – volume: 67 start-page: 619 year: 1996 ident: e_1_2_5_14_1 article-title: Reliability of refraction–a literature review publication-title: J Am Optom Assoc – ident: e_1_2_5_26_1 doi: 10.1167/iovs.05-0843 – ident: e_1_2_5_24_1 doi: 10.1097/00006324-199607000-00006 – ident: e_1_2_5_3_1 doi: 10.1159/000327703 – ident: e_1_2_5_13_1 doi: 10.1089/jop.2000.16.121 – ident: e_1_2_5_10_1 doi: 10.1097/OPX.0000000000000705 – ident: e_1_2_5_25_1 doi: 10.1167/iovs.03-0122 – ident: e_1_2_5_22_1 doi: 10.1136/bjo.68.2.113 |
| SSID | ssj0061664 |
| Score | 2.2879646 |
| Snippet | Purpose
To examine visual acuity, refraction and ocular status before, during and after hyperbaric oxygen therapy (HBOT).
Methods
Twenty‐nine patients... To examine visual acuity, refraction and ocular status before, during and after hyperbaric oxygen therapy (HBOT). Twenty-nine patients underwent 40 standard... PurposeTo examine visual acuity, refraction and ocular status before, during and after hyperbaric oxygen therapy (HBOT).MethodsTwenty‐nine patients underwent... To examine visual acuity, refraction and ocular status before, during and after hyperbaric oxygen therapy (HBOT).PURPOSETo examine visual acuity, refraction... PURPOSE: To examine visual acuity, refraction and ocular status before, during and after hyperbaric oxygen therapy (HBOT). METHODS: Twenty-nine patients... To examine visual acuity, refraction and ocular status before, during and after hyperbaric oxygen therapy (HBOT).Twenty-nine patients underwent 40 standard... |
| SourceID | swepub proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 596 |
| SubjectTerms | Acuity Anterior chamber Blood pressure Cataract Cohort analysis Cornea Eye Hyperbaric oxygen therapy Myopia myopic shift Observational studies Oftalmologi Ophthalmology Oxidative stress Oxygen therapy Refraction Respiratory therapy Turbidity |
| Title | Myopic shift and lens turbidity following hyperbaric oxygen therapy – a prospective, longitudinal, observational cohort study |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Faos.14010 https://www.ncbi.nlm.nih.gov/pubmed/30690920 https://www.proquest.com/docview/2269768245 https://www.proquest.com/docview/2179420481 https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-103792 https://gup.ub.gu.se/publication/278674 |
| Volume | 97 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fa9RAEF9KBfHF-t-rtawi4kNz5Dab3QSfrtajCFXQKvcgLLub3ethSY5LgtQX-x36Df0kzuQfViuID4GQnSS7yUzmN9nZ3xDyDGIbr7n1gdBgTdxFIki9lYEV0kmeusjYJsv3rTj8yN_M4_kGedmvhWn5IYYfbmgZzfcaDVyb8hcj10U5xugA43XM1UJA9H6gjhIT0VBHgXeMwYjieccqhFk8w5mXfdEfAHNgD70MXBvPM9sin_s-twknX8Z1Zcb22290jv85qFvkZodI6bRVodtkw-V3yPWjbs79Lvl-dFaslpaWJ0tfUZ1nFBxVScFVmWUGGJ56UKXiK7hAegJBLU5fgDT0FVSTtsu7zuiP8wuqKQyhX9m5R08LLJVUZ1iWa48WZvg9DJ3Bsr3rijbct_fI8ez18avDoCvbEFgueBjYSFunEQoaZsNMhgAxJ5PMpt5FXurUgN90IvFGiCSJU5YJLRJm4lBkUhsf3SebeZG7h4SyRGhmI85NmnCWhaljOom19xLLCnI2Ii_696dsR2mOlTVOVR_awPNUzfMckaeD6Krl8bhKaKdXAtWZcqkAnwJkSxiPR-TJ0AxGiDMrOndFDTL4WUMK5MmIPGiVZ7hLhFzQKYOLP2-1aWhBZu-D5aepKtYL2GqFazZTdrXgol4pOLSoVekUk4mQHIbf6NLfB6Sm7z40O9v_LvqI3ABQ2OXR7ZDNal27xwC8KrNLrk33D_Znu42l_QRQyC6I |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9QwFA7LCuqL98voqlFEfNgOnTRNW_BlUJdRd1bQUeZlCUmazA4u02HaIuuL_gf_ob_Ec9ILrq4gPhRKc9om6Tk938nlO4Q8htjGKW5cIBRYE7eRCDJnksCIxCY8s5E2fpXvgZh84K_n8XyLPOv2wjT8EP2AG1qG_1-jgeOA9C9WropyiOEBBOznMKO3D6je9eRRYiQ8eRT4xxjMKJ63vEK4jqe_9bQ3-gNi9vyhp6Gr9z17l8lhV-tmycmnYV3pofnyG6Hj_zbrCrnUglI6brToKtmyq2vk_LSddr9Ovk5PivXS0PJo6SqqVjkFX1VS8FZ6mQOMpw60qfgMXpAeQVyLMxggDZUF7aTNDq8T-uPbd6ootKHb3LlLjwvMllTnmJlrlxa6HyGGymDm3k1FPf3tDTLbezl7PgnazA2B4YKHgYmUsQrRoGYmzJMQUOZolJvM2cglKtPgOq1InRYiTeOM5UKJlOk4FHmitItuku1VsbK3CWWpUMxEnOss5SwPM8tUGivnEswsyNmAPO0-oDQtqzkm1ziWXXQD_Sl9fw7Io1503VB5nCW002mBbK25lABRAbWljMcD8rAvBjvEyRW1skUNMvhnQxbk0YDcarSnf0uEdNAZg4c_adSpL0Fy7xfLj2NZbBZw1BK3bWbsbMFFvZZwaVHL0kqWpCLh0HyvTH9vkBy_fe9P7vy76ANyYTKb7sv9Vwdv7pKLgBHbZXU7ZLva1PYe4LBK3_fm9hOFaDEx |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqVqq4QMtz-wCDEOLQrLKOYzvitGJZlUcLgoL2gGTZjr1dUSWrTSJULvAf-If8EsZ5iUKREIdIUTxJbGcm840f3yD0EGIbp6hxAVNgTdRGLEic4YFh3HKa2EibepXvMTt8T1_M4tkaetLthWn4IfoBN28Z9f_aG_gydb8YucqLoY8OIF7foCwUXqUnb3vuKDZiNXcUuMcYrCietbRCfhlPf-tFZ_QHwuzpQy8i19r1TK-hj12lmxUnn4ZVqYfmy298jv_Zqi10tYWkeNzo0DZas9l1tHnUTrrfQF-PzvPlwuDidOFKrLIUg6cqMPgqvUgBxGMHupR_Bh-ITyGq9fMXIA11Bd3Ezf6uc_zj23esMDSh29p5gM9ynyupSn1ergOc6358GCrj8_auSlyT395EJ9NnJ08PgzZvQ2Aoo2FgImWs8lhQExOmPASMORqlJnE2clwlGhynZcJpxoSIE5IyxQTRcchSrrSLbqH1LM_sHYSJYIqYiFKdCErSMLFEiVg5x31eQUoG6HH3_aRpOc19ao0z2cU20J-y7s8BetCLLhsij8uE9jolkK0tFxIAKmA2QWg8QPf7YrBCP7WiMptXIOP_a54DeTRAtxvl6d8SeTLohMDDHzXa1Jd4au_J4sNY5qs5HJX0mzYTcrngvFpKuDSvZGEl4YJxCs2vdenvDZLj1-_qk51_F72HNt9MpvLV8-OXu-gKAMR2Td0eWi9Xld0HEFbqu7Wx_QT4Fi_p |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Myopic+shift+and+lens+turbidity+following+hyperbaric+oxygen+therapy+%E2%80%93+a+prospective%2C+longitudinal%2C+observational+cohort+study&rft.jtitle=Acta+ophthalmologica+%28Oxford%2C+England%29&rft.au=Riedl%2C+Philip&rft.au=%C5%A0kilji%C4%87%2C+Dragana&rft.au=Arnell%2C+Per&rft.au=Wannholt%2C+Roger&rft.date=2019-09-01&rft.issn=1755-375X&rft.eissn=1755-3768&rft.volume=97&rft.issue=6&rft.spage=596&rft.epage=602&rft_id=info:doi/10.1111%2Faos.14010&rft.externalDBID=10.1111%252Faos.14010&rft.externalDocID=AOS14010 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1755-375X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1755-375X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1755-375X&client=summon |